vs
Side-by-side financial comparison of Church & Dwight (CHD) and CME Group (CME). Click either name above to swap in a different company.
CME Group is the larger business by last-quarter revenue ($1.9B vs $1.6B, roughly 1.1× Church & Dwight). Church & Dwight runs the higher net margin — 8.7% vs 0.1%, a 8.7% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 3.9%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 4.6%).
Church & Dwight Co., Inc., is an American consumer goods company focusing on personal care, household products, and specialty products. The company was founded in 1847 and is headquartered in Ewing, New Jersey. It is the parent company of well-known brands such as Arm & Hammer, Trojan, OxiClean, and First Response. In 2022, Church & Dwight reported annual revenue of $5.4 billion. The company's products and services include a wide range of consumer goods, including laundry detergent, air fresh...
CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...
CHD vs CME — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.9B |
| Net Profit | $143.5M | $1.2M |
| Gross Margin | 45.8% | — |
| Operating Margin | 16.2% | 0.1% |
| Net Margin | 8.7% | 0.1% |
| Revenue YoY | 3.9% | 14.5% |
| Net Profit YoY | -24.2% | 20.7% |
| EPS (diluted) | $0.60 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.9B | ||
| Q4 25 | $1.6B | $1.6B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.5B | $1.7B | ||
| Q1 25 | $1.5B | $1.6B | ||
| Q4 24 | $1.6B | $1.5B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.5B | $1.5B |
| Q1 26 | — | $1.2M | ||
| Q4 25 | $143.5M | $1.2B | ||
| Q3 25 | $182.2M | $908.0M | ||
| Q2 25 | $191.0M | $1.0B | ||
| Q1 25 | $220.1M | $956.2M | ||
| Q4 24 | $189.2M | $874.6M | ||
| Q3 24 | $-75.1M | $912.8M | ||
| Q2 24 | $243.5M | $883.2M |
| Q1 26 | — | — | ||
| Q4 25 | 45.8% | — | ||
| Q3 25 | 45.1% | — | ||
| Q2 25 | 43.0% | — | ||
| Q1 25 | 45.0% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 45.2% | — | ||
| Q2 24 | 47.1% | — |
| Q1 26 | — | 0.1% | ||
| Q4 25 | 16.2% | 61.8% | ||
| Q3 25 | 16.1% | 63.3% | ||
| Q2 25 | 17.4% | 66.7% | ||
| Q1 25 | 20.1% | 67.5% | ||
| Q4 24 | 16.2% | 62.1% | ||
| Q3 24 | -6.1% | 64.6% | ||
| Q2 24 | 22.3% | 65.3% |
| Q1 26 | — | 0.1% | ||
| Q4 25 | 8.7% | 71.7% | ||
| Q3 25 | 11.5% | 59.1% | ||
| Q2 25 | 12.7% | 60.6% | ||
| Q1 25 | 15.0% | 58.2% | ||
| Q4 24 | 12.0% | 57.3% | ||
| Q3 24 | -5.0% | 57.6% | ||
| Q2 24 | 16.1% | 57.6% |
| Q1 26 | — | — | ||
| Q4 25 | $0.60 | $3.24 | ||
| Q3 25 | $0.75 | $2.49 | ||
| Q2 25 | $0.78 | $2.81 | ||
| Q1 25 | $0.89 | $2.62 | ||
| Q4 24 | $0.76 | $2.40 | ||
| Q3 24 | $-0.31 | $2.50 | ||
| Q2 24 | $0.99 | $2.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.0M | $2.4B |
| Total DebtLower is stronger | $2.2B | $3.4B |
| Stockholders' EquityBook value | $4.0B | — |
| Total Assets | $8.9B | $202.0B |
| Debt / EquityLower = less leverage | 0.55× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.4B | ||
| Q4 25 | $409.0M | $4.5B | ||
| Q3 25 | $305.3M | $2.6B | ||
| Q2 25 | $923.2M | $2.1B | ||
| Q1 25 | $1.1B | $1.5B | ||
| Q4 24 | $964.1M | $3.0B | ||
| Q3 24 | $752.1M | $2.4B | ||
| Q2 24 | $491.7M | $1.9B |
| Q1 26 | — | $3.4B | ||
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | — |
| Q1 26 | — | — | ||
| Q4 25 | $4.0B | $28.7B | ||
| Q3 25 | $4.2B | $28.2B | ||
| Q2 25 | $4.4B | $27.7B | ||
| Q1 25 | $4.6B | $27.0B | ||
| Q4 24 | $4.4B | $26.5B | ||
| Q3 24 | $4.2B | $28.2B | ||
| Q2 24 | $4.3B | $27.6B |
| Q1 26 | — | $202.0B | ||
| Q4 25 | $8.9B | $198.4B | ||
| Q3 25 | $9.1B | $187.1B | ||
| Q2 25 | $8.8B | $179.9B | ||
| Q1 25 | $9.0B | $157.8B | ||
| Q4 24 | $8.9B | $137.4B | ||
| Q3 24 | $8.7B | $137.8B | ||
| Q2 24 | $8.8B | $123.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.55× | — | ||
| Q3 25 | 0.52× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 0.51× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHD
| Household Products | $645.3M | 39% |
| Personal Care Products | $625.9M | 38% |
| Consumer International | $299.8M | 18% |
| Specialty Products Division | $73.2M | 4% |
CME
Segment breakdown not available.
